Skip to content

Author

Ali Naderi Malek

We have 2 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Cognitive-behavioral phenotypes in FMR1 premutation carriers: a cross-population comparison with mild cognitive impairment

Introduction Carriers of the FMR1 premutation are at risk for cognitive decline, though premutation-specific markers of age-related risk are largely unknown. One approach to determining relevant risk markers is to assess cross-population comparisons with individuals with known clinical trajectories. Methods The present...

N. Maltman, Jessica L. Greenlee, K. Mueller et al. · 0 citations
Review Open access Aug 2026

Gene Therapy for Autism Spectrum Disorder: Preclinical Advances, Translational Barriers, and Ethical Dimensions - A Scoping Review.

Gene therapy for ASD shows considerable promise but faces significant translational and ethical hurdles and standardized study designs, comprehensive safety evaluation, and transparent stakeholder engagement will be critical for developing responsible and effective clinical applications.

Ali Naderi Malek, Amir Hossein Rasoli Jokar, Patricia A. Prelock · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.